急性中风后的痛风爆发:一个单中心队列和系统性审查/元分析
Evangelos Panagiotopoulos1, Vasiliki Kotsali-Peteinelli1, Georgia Papagiannopoulou1
1Second Department of Neurology, School of Medicine, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Neurological research and practice
|October 15, 2025
概括
急性中风患者有4%的痛风发作,通常发生在一周内,影响肢. 这凸显了对中风幸存者的痛风早期诊断和治疗的需要.
科学领域:
- 神经学 神经学
- 类风湿病学 类风湿病学
- 心脏病学 心脏病学
背景情况:
- 在全球范围内,高尿血和痛风的患病率正在上升.
- 在痛风爆发和心血管事件之间建立了联系.
- 没有充分研究中风和痛风爆发之间的关联.
研究的目的:
- 评估中风后痛风爆发的发生率和特征.
- 评估相反的关联:中风引发痛风爆发.
- 将队列数据与系统审查和元分析结合起来.
主要方法:
- 发表的研究的系统审查和元分析.
- 包括一个单中心急性中风患者队列.
- 随机效应模型用于聚合发病率和爆发时间估计.
主要成果:
- 住院痛风爆发的综合发病率:4% (95% CI,2-6%).
- 发作发作的平均时间:中风后6.3天;64%的人涉及肢.
- 在患有缺血性中风 (97%) 的男性 (85%) 中常见的爆发; 61% 新诊断的痛风/高尿血.
结论:
- 痛风发作会影响25个急性中风患者中的1个,特别是在第一周内患有缺血性中风的男性.
- 爆发频繁涉及肢,可以揭示未被诊断的痛风.
- 系统评估至关重要,特别是在患有妄想症或沟通障碍的患者中;早期的菌素可能是有益的.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
209
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
209
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
351
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
351
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
476
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
476
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
349
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
349
Acute Coronary Syndrome I: Introduction
794
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
794
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319


